Through innovative R&D in nanomedicine, we seek to restore freedom, happiness, and the ability to live fully to those affected by cancer.
The formulation is engineered for biocompatibility and biodegradability through a proprietary 16-step nanoprocessing method.
Onselex has built a broad intellectual property portfolio covering its nanoparticle platform and potential applications.
Onselex is expanding its pipeline by developing innovative and effective new drugs.
Pancreatic/Liver Cancer Nanomedicine
Ovarian Cancer Nanomedicine
Gastric/Colorectal Cancer Oral Nanomedicine
Company History
Leadership
May pursue strategic partnerships with global pharmaceutical companies, including co-development, licensing, and commercialization.
Freedom, happiness, and a return to normal life.